GlassScriptPhysician profile
Srinivas Gatla
NPI 1679885388
$4,089.15
in general payments reported to CMS, 2019-2025
38 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $386 · 2021: $677 · 2022: $802 · 2023: $778 · 2024: $616 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $633.95 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novartis Pharmaceuticals Corporation | $407.70 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $305.61 | 2019-2024 | Verquvo |
| Lilly USA, LLC | $291.05 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Amgen INC. | $286.60 | 2019-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $259.27 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $216.21 | 2020-2022 | |
| Pfizer INC. | $179.94 | 2019-2025 | |
| Abbott Laboratories | $163.82 | 2021-2025 | Freestyle Libre 3 |
| Abbvie INC. | $158.81 | 2021-2023 | |
| Dexcom, INC. | $129.14 | 2021-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.96 | 2024-2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $113.55 | 2023-2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $100.95 | 2022-2025 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $97.77 | 2022-2025 | Trelegy Ellipta, Shingrix |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Gatla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.